Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | (FY)Aug 31, 2021 | (FY)Aug 31, 2020 | (FY)Aug 31, 2019 | (FY)Aug 31, 2018 | (FY)Aug 31, 2017 | (FY)Aug 31, 2016 | (FY)Aug 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -109.53%-141.83M | 188.16%1.49B | -67.17%516.4M | 125.00%1.57B | -56.15%699.03M | 39.74%1.59B | -31.73%1.14B | 38.93%1.67B | 3.84%1.2B | -1.22%1.16B |
Net profit before non-cash adjustment | -36.98%731.3M | -35.63%1.16B | 193.05%1.8B | -10.21%615.11M | -32.27%685.03M | -6.77%1.01B | -4.74%1.08B | 5.56%1.14B | -48.75%1.08B | 82.11%2.11B |
Total adjustment of non-cash items | 95.86%-16.26M | 59.47%-392.62M | -3,238.06%-968.81M | -90.16%30.87M | -26.10%313.88M | 68.71%424.73M | 187.04%251.76M | -84.89%87.71M | 585.64%580.57M | -15.04%-119.55M |
-Depreciation and amortization | 7.97%271.35M | -11.89%251.31M | 5.76%285.21M | -16.82%269.67M | 3.03%324.2M | -5.05%314.67M | -12.86%331.43M | 19.34%380.34M | 27.44%318.7M | 10.59%250.09M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 33.12%8.42M | -85.38%6.33M | --43.28M | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.79%5.87M | 275.62%25.3M |
-Disposal profit | 239.79%20.28M | 35.24%-14.51M | -117.76%-22.4M | -126.22%-10.29M | 228.67%39.24M | -354.40%-30.5M | 109.09%11.99M | -273.99%-131.96M | 180.90%75.85M | 42.17%-93.76M |
-Net exchange gains and losses | 125.31%96.71M | 67.63%-382.05M | -557.60%-1.18B | -1,986.27%-179.46M | -93.81%9.51M | 1,095.47%153.61M | 85.28%-15.43M | -148.82%-104.81M | 217.01%214.67M | -48.30%-183.47M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 49.73%-15.1M | -230.18%-30.05M |
-Other non-cash items | -63.56%-404.61M | -380.44%-247.37M | 10.41%-51.49M | 12.13%-57.47M | -16.09%-65.4M | 26.09%-56.34M | -36.45%-76.23M | -187.77%-55.87M | 77.85%-19.41M | -18.38%-87.66M |
Changes in working capital | -218.97%-856.87M | 326.94%720.27M | -134.24%-317.38M | 409.06%926.82M | -289.83%-299.88M | 180.65%157.98M | -144.07%-195.88M | 197.31%444.43M | 44.79%-456.72M | -786.00%-827.25M |
-Change in receivables | -233.87%-561.41M | 276.76%419.38M | -129.27%-237.26M | 677.00%810.51M | 3,980.69%104.31M | -103.05%-2.69M | 177.53%88.19M | -383.86%-113.75M | 96.90%-23.51M | -458.13%-757.81M |
-Change in inventory | -642.38%-654.5M | -29.57%120.67M | 280.59%171.33M | 4.06%-94.87M | -70.51%-98.89M | 86.45%-58M | -314.33%-427.93M | 47.30%199.66M | -45.67%135.54M | 190.07%249.5M |
-Change in payables | 424.92%173.82M | -373.06%-53.5M | 642.99%19.59M | 96.10%-3.61M | -780.96%-92.59M | 81.58%-10.51M | -141.09%-57.06M | 380.49%138.86M | -315.45%-49.51M | 373.09%22.98M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -239.66%-106.47M | 152.15%76.24M |
-Provision for loans, leases and other losses | 62.92%33.34M | -71.79%20.46M | 786.93%72.52M | 162.61%8.18M | -138.86%-13.06M | -51.44%33.61M | 299.35%69.22M | ---34.72M | ---- | ---- |
-Changes in other current assets | -49.18%99.28M | 149.61%195.34M | -281.54%-393.76M | 489.67%216.89M | -142.94%-55.66M | 1,392.00%129.64M | -111.20%-10.03M | 186.62%89.59M | -875.08%-103.43M | -35.98%13.34M |
-Changes in other current liabilities | 193.70%52.61M | -64.31%17.91M | 587.99%50.19M | 92.86%-10.29M | -318.45%-144M | -53.49%65.92M | -13.99%141.74M | 153.27%164.8M | 28.31%-309.35M | -431.77%-431.49M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -23.42%-917K | -607.62%-743K | 82.56%-105K | 26.59%-602K | 30.68%-820K | -141.43%-1.18M | 53.69%-490K | 16.50%-1.06M | 23.21%-1.27M | 12.56%-1.65M |
Interest received (cash flow from operating activities) | 42.77%389.34M | 262.16%272.71M | 50.80%75.3M | -28.53%49.93M | -16.00%69.87M | 44.74%83.18M | 10.64%57.47M | -24.84%51.94M | -29.34%69.11M | -2.98%97.8M |
Tax refund paid | 75.98%-199.58M | -306.41%-830.86M | -68.57%-204.44M | 58.77%-121.28M | 10.66%-294.12M | 21.07%-329.23M | -169.93%-417.11M | 80.86%-154.53M | -80.63%-807.19M | -78.73%-446.87M |
Other operating cash inflow (outflow) | -300.00%-2K | 200.00%1K | -1K | 0 | 0.00%-1K | 0.00%-1K | 0.00%-1K | -1K | 0 | 0 |
Operating cash flow | -94.94%47.01M | 140.00%929.16M | -74.20%387.15M | 216.66%1.5B | -64.81%473.96M | 72.53%1.35B | -50.19%780.67M | 238.20%1.57B | -42.61%463.46M | -20.94%807.62M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -12.16%-250.59M | -89.60%-223.43M | -33.97%-117.84M | 45.88%-87.96M | 48.49%-162.52M | -99.30%-315.5M | 1.60%-158.31M | 88.55%-160.88M | -127.34%-1.41B | -7.99%-618.29M |
Net intangibles purchase and sale | 96.70%-381K | -2.69%-11.54M | ---11.23M | ---- | -357.88%-1.25M | 97.66%-273K | -177.90%-11.67M | -94.44%-4.2M | -91.83%-2.16M | 40.52%-1.13M |
Net investment product transactions | 3,578.84%836.83M | -107.51%-24.06M | 73.71%320.33M | -20.70%184.4M | 0.31%232.54M | 356.14%231.82M | -208.51%-90.51M | -81.41%83.41M | 24.15%448.58M | -42.24%361.31M |
Net changes in other investments | 50.00%-1K | ---2K | ---- | 0.00%-2K | ---2K | ---- | ---- | ---1K | ---- | 50.00%-1K |
Investing cash flow | 326.18%585.86M | -235.44%-259.02M | 98.32%191.25M | 40.23%96.44M | 181.92%68.77M | 67.77%-83.95M | -218.92%-260.48M | 91.49%-81.68M | -271.64%-959.22M | -604.61%-258.1M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -125.23%-103.3M | --409.4M | --0 | -192.89%-379M | -181.51%-129.4M | -34.54%158.75M | 120.86%242.53M | -237.27%-1.16B | 273.09%846.81M | 11.18%-489.22M |
Net common stock issuance | -492.58%-1.37B | -360.48%-232.01M | -63.14%-50.39M | -100.08%-30.88M | 88.14%-15.44M | -209,835.48%-130.16M | 99.95%-62K | -63.38%-121.32M | 42.20%-74.26M | -149.34%-128.46M |
Cash dividends paid | 6.45%-45.92M | 0.75%-49.09M | 36.28%-49.46M | 30.83%-77.62M | 4.17%-112.22M | -26.43%-117.11M | 11.51%-92.63M | 23.88%-104.67M | -68.40%-137.5M | -25.25%-81.65M |
Net other fund-raising expenses | ---- | ---1K | ---- | 0.00%-1K | ---1K | ---- | 0.00%-1K | 0.00%-1K | 0.00%-1K | ---1K |
Financing cash flow | -1,287.88%-1.52B | 228.51%128.3M | 79.52%-99.84M | -89.65%-487.5M | -190.41%-257.06M | -159.07%-88.52M | 110.79%149.84M | -318.63%-1.39B | 190.81%635.05M | -4.77%-699.33M |
Net cash flow | ||||||||||
Beginning cash position | 19.02%7.44B | 36.78%6.25B | 38.54%4.57B | 9.44%3.3B | 53.63%3.01B | 53.96%1.96B | 17.44%1.27B | -2.25%1.08B | -2.11%1.11B | 64.37%1.13B |
Current changes in cash | -211.62%-891.2M | 66.84%798.44M | -56.88%478.56M | 288.48%1.11B | -75.68%285.68M | 75.28%1.17B | 588.14%670.03M | -30.10%97.37M | 192.97%139.29M | -136.98%-149.82M |
Effect of exchange rate changes | -108.95%-34.94M | -67.53%390.38M | 644.75%1.2B | 14,015.95%161.43M | 99.05%-1.16M | -798.78%-122.28M | -80.96%17.5M | 155.93%91.9M | -230.48%-164.3M | 223.95%125.92M |
Cash adjustments other than cash changes | 200.00%1K | -150.00%-1K | 100.00%2K | --1K | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | -12.45%6.51B | 19.02%7.44B | 36.78%6.25B | 38.54%4.57B | 9.44%3.3B | 53.63%3.01B | 53.96%1.96B | 17.44%1.27B | -2.25%1.08B | -2.11%1.11B |
Free cash flow | -130.19%-209.17M | 176.53%692.92M | -81.92%250.58M | 384.91%1.39B | -72.21%285.8M | 69.33%1.03B | -56.63%607.31M | 248.30%1.4B | -610.23%-944.33M | -58.51%185.08M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |